1. Home
  2. AEIS vs GKOS Comparison

AEIS vs GKOS Comparison

Compare AEIS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEIS
  • GKOS
  • Stock Information
  • Founded
  • AEIS 1981
  • GKOS 1998
  • Country
  • AEIS United States
  • GKOS United States
  • Employees
  • AEIS N/A
  • GKOS N/A
  • Industry
  • AEIS Industrial Machinery/Components
  • GKOS Medical/Dental Instruments
  • Sector
  • AEIS Technology
  • GKOS Health Care
  • Exchange
  • AEIS Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • AEIS 5.3B
  • GKOS 5.8B
  • IPO Year
  • AEIS 1995
  • GKOS 2015
  • Fundamental
  • Price
  • AEIS $148.73
  • GKOS $95.78
  • Analyst Decision
  • AEIS Buy
  • GKOS Strong Buy
  • Analyst Count
  • AEIS 10
  • GKOS 12
  • Target Price
  • AEIS $140.70
  • GKOS $131.17
  • AVG Volume (30 Days)
  • AEIS 494.6K
  • GKOS 774.9K
  • Earning Date
  • AEIS 10-29-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • AEIS 0.27%
  • GKOS N/A
  • EPS Growth
  • AEIS N/A
  • GKOS N/A
  • EPS
  • AEIS 2.22
  • GKOS N/A
  • Revenue
  • AEIS $1,635,742,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • AEIS $19.29
  • GKOS $28.79
  • Revenue Next Year
  • AEIS $7.24
  • GKOS $25.65
  • P/E Ratio
  • AEIS $67.44
  • GKOS N/A
  • Revenue Growth
  • AEIS 8.49
  • GKOS 26.70
  • 52 Week Low
  • AEIS $75.01
  • GKOS $77.10
  • 52 Week High
  • AEIS $163.08
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • AEIS 58.39
  • GKOS 59.15
  • Support Level
  • AEIS $151.62
  • GKOS $91.43
  • Resistance Level
  • AEIS $156.91
  • GKOS $94.71
  • Average True Range (ATR)
  • AEIS 4.77
  • GKOS 2.57
  • MACD
  • AEIS -0.31
  • GKOS 1.11
  • Stochastic Oscillator
  • AEIS 57.24
  • GKOS 96.81

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: